PCI Pharma Services Acquires Lyophilization Services of New England (LSNE)

Novacap Acquires PCI Synthesis

June 28, 2018

Pharmaceuticals

Novacap has completed the acquisition of PCI Synthesis, a U.S.-based small-molecule CDMO with R&D and manufacturing sites in Massachusetts. The deal gives Novacap a U.S. footprint and strengthens its global pharmaceutical synthesis and commercial manufacturing capabilities.

PCI Pharma Services Acquires Ajinomoto Althea

May 1, 2025

Healthcare Services

PCI Pharma Services has completed the acquisition of Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO previously owned by Ajinomoto Co., Inc. The deal expands PCI’s US sterile manufacturing footprint in San Diego—adding prefilled syringe and cartridge aseptic capabilities, lyophilization and high-potent vial filling (including ADC support)—and is part of a multi-year, roughly $1 billion investment strategy to broaden advanced drug delivery and fill‑finish capacity.

Bain Capital and Kohlberg Lead Strategic Investment in PCI Pharma Services

July 14, 2025

Healthcare Services

PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), received a strategic growth investment co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from Mubadala and a continuing minority stake from Partners Group. The capital will be used to accelerate PCI's organic and inorganic growth, expand sterile fill-finish and specialized manufacturing capacity, and broaden its geographic footprint to support biopharma customers and U.S. pharmaceutical supply-chain resilience.

PCI Pharma Services Acquires Bellwyck Pharma Services

February 11, 2020

Healthcare Services

PCI Pharma Services announced the acquisition of Bellwyck Pharma Services, a Toronto-headquartered clinical and commercial packaging, labeling and clinical trial services provider. The deal adds four GMP-compliant facilities in the U.S., Germany and Canada to PCI's global network and expands PCI's clinical trial service footprint into Canada and continental Europe.

Myonex Acquires Creapharm's Pharmaceutical Services Business

May 2, 2024

Pharmaceuticals

Myonex has completed the acquisition of Creapharm's pharmaceutical services business, integrating Creapharm's clinical packaging, commercial packaging and bioservices into its global clinical trial supply platform. The deal brings Creapharm's cold-chain and ultra-cold capabilities and expands Myonex's service offering and European footprint; Creapharm founder Eric Placet has reinvested and joined the Myonex board.

Alcami Corporation Acquires Pacific Pharmaceutical Services

January 17, 2024

Healthcare Services

Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.